EFFECT OF TAURINE ON MANIFESTATION OF AUDIOGENIC EPILEPSY IN RATS WITH PENDULUM MOVEMENTS

Cover Page

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

A decrease of taurine in hippocampus of the line of rats with pendulum movements (PM), predisposed to audiogenic epilepsy, was shown. Taurine (aminoethanesulfonic acid) is known to be an anticonvulsant drug. The aim of the present work was to verify the predictive validity of taurine in rats with pendulum movements (PM). In neonatal period the exogenous taurine administration did not influence a convulsive activity at the age of 1.5 and 3 months in PM rats. The increase in the number of audiogenic seizures after taurine injections was found in adolescent period in 1.5 months and in prolonged point – in 3 months. The number of abortive seizures decreased under acute injection of taurine in adult PM rats, but the level of ictal and postictal indicators restored one month later, at the age of 4 months. Obtained results indicate the absence of effect of taurine administered to rats in the neonatal age, while at the long-term scale, the rats showed the increasing seizure activity under the action of taurine in adolescent period and confirm the predictive validity of this drug in adult PM rats.

About the authors

T. A. Alekhina

Institute of Cytology and Genetics

Author for correspondence.
Email: alek@bionet.nsc.ru
Russia, Novosibirsk

References

  1. Акулов А.Е., Алехина Т.А., Мешков И.О., Петровский Е.Д., Прокудина О.И., Коптюг И.В., Савелов А.А., Мошкин М.П. Отбор на кататонический тип реагирования у крыс: исследование межлинейных различий методом магнитно-резонансной томографии. Журнал высш. нервн. деят. им. И.П. Павлова. 2014. 64 (4): 439–447.
  2. Алехина Т.А., Кожемякина Р.В. Моделирование фокальных приступов с автоматизмами на крысах с маятникообразными движениями. Бюлл. эксп. биол. мед. 2019. 168 (8): 300–303.
  3. Алехина Т.А., Плеканчук В.С., Осадчук Л.В. Продромальные характеристики эпилепсии у крыс с маятникообразными движениями. Ж. эволюц. биохим. физиол. 2021. 57 (3): 240–249. https://doi.org/10.31857/S0044452921030025
  4. Алехина Т.А., Прокудина О.И., Рязанова М.А., Уколова Т.Н., Барыкина Н.Н., Колпаков В.Г. Проявление типологических свойств поведения у линий крыс, селекционированных на усиление и отсутствие маятникообразных движений. Связь с моноаминами мозга. Журнал высш. нервн. деят. им. И.П. Павлова. 2007. 57 (3): 336–343.
  5. Семиохина А.Ф., Федотова И.Б., Полетаева И.И. Крысы линии Крушинского-Молодкиной: исследования аудиогенной эпилепсии, сосудистой патологии и поведения. Журнал высш. нервн. деят. им. И.П. Павлова. 2006. 56 (3): 298–316.
  6. Avanzini C., Franceschetti S. Cellular biology of epileptogenesis. Lanset Neurol. 2003. 2: 33–42.
  7. Avoli M., Louvel J., Pumain R., Kohling R. Cellular and molecular mechanisms of epilepsy in the human brain. Prog Neurobiol. 2005. 77: 166–200.
  8. Chen W.G., Jin H., Nguyen M., Carr J., Lee Y.J., Hsu C.C., Faiman M.D., Schloss J.W., Wu J.Y. Role of taurine in regulation of intracellular calcium level and neuroprotective function in cultured neurons. J. Neurpsci. Res. 2001. 66: 612–619.
  9. Idrissi A. Taurine Regulation of Neuroendocrine Function. Adv Exp Med Biol. 2019;1155:977-985. https://doi.org/10.1007/978-981-13-8023-5_81
  10. Holmes G.L., Ben-Ari Y. The neurobiology and consequences of epilepsy in the development brain. Pediatr Res. 2001. 49: 320–325.
  11. Loscher W., Kohling R. Functional, metabolic and synaptic changes after seizures as potential targets for antiepileptic therapy. Epilepsy Behav. 2010. 19: 105–113.
  12. Kilb W., Fukuda A. Taurine as an essential neuromodulator during perinatal cortical development. Front. Cell. Neurosci. 2017. 11: 328. https://doi.org/10.3389/frcel.2017.00328
  13. Kohling R. Prolong seizures: what are the mechanism that predisposed or cease to be protective? A review of animal data. Epileptic disorg. 2014. 16 (Suppl. 1): S23–S36.
  14. Kubova H., Mares P. Suppression of cortical epileptic after discharges by ketamine is not stable during ontogenesis in rats. Pharmacol Biochem Behav. 1995. 52 (3): 489–492.
  15. Oja S.S., Saransaari P. Taurine and epilepsy. Epilepsy Res. 2013. 104: 187–194.
  16. Ripps H., Shen W. Review: Taurine: a “very essential” amino acid. Molecular vision. 2012. 18: 2673–2686. http://www.molvis.org/molvis/v18/a275
  17. Schaffer S., Kim H.W. Effects and Mechanisms of Taurine as a Therapeutic Agent. Biomol Ther (Seoul). 2018. 1; 26 (3): 225–241. https://doi.org/10.4062/biomolther.2017.251

Supplementary files

Supplementary Files
Action
1. JATS XML
2.

Download (27KB)
3.

Download (56KB)
4.

Download (47KB)
5.

Download (41KB)

Copyright (c) 2023 Т.А. Алехина